Sangamo Therapeutics Inc.

NASDAQ: SGMO · Real-Time Price · USD
0.58
0.04 (7.41%)
At close: Aug 15, 2025, 3:59 PM
0.59
1.21%
After-hours: Aug 15, 2025, 07:49 PM EDT

Sangamo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-97.94M -257.83M -192.28M -178.3M
Depreciation & Amortization
9.36M 22.19M 20.56M 17.64M
Stock-Based Compensation
12.38M 27.36M 31.65M 32.96M
Other Working Capital
17.72M -168.65M -98M -101.11M
Other Non-Cash Items
4.55M 153.8M -1.24M -6.43M
Deferred Income Tax
n/a -6.33M n/a 2.77M
Change in Working Capital
4.51M -164.03M -82.32M -101.89M
Operating Cash Flow
-67.14M -224.84M -223.63M -233.25M
Capital Expenditures
-267K -21.16M -20.17M -23.28M
Cash Acquisitions
1.95M n/a -79.46M -119K
Purchase of Investments
n/a -59.55M -277.39M -338.16M
Sales Maturities Of Investments
35.84M 234.24M 356.85M 609.75M
Other Investing Acitivies
n/a n/a 79.46M n/a
Investing Cash Flow
37.52M 153.53M 59.28M 248.2M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-614K -518K -209K 5.76M
Financial Cash Flow
28.38M 14.59M 84.66M 32.86M
Net Cash Flow
-3.29M -55.24M -78.43M 47.54M
Free Cash Flow
-67.41M -246M -243.8M -256.53M